Reynders Mc Veigh Capital Management, LLC Pacific Biosciences Of California, Inc. Transaction History

Reynders Mc Veigh Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$4.02 - $10.43 $456,189 - $1.18 Million	-113,480 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$8.43 - $20.9 $269,507 - $668,173	-31,970 Reduced 21.98%	113,480 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$19.26 - $30.08 $283,507 - $442,777	14,720 Added 11.26%	145,450 $2.98 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $292,477 - $412,010	11,765 Added 9.89%	130,730 $3.34 Million
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $329,594 - $532,375	14,780 Added 14.19%	118,965 $4.16 Million
Q1 2021 May 07, 2021	BUY	$26.38 - $51.15 $951,130 - $1.84 Million	36,055 Added 52.92%	104,185 $3.47 Million
Q4 2020 Feb 10, 2021	BUY	$10.5 - $28.5 $715,365 - $1.94 Million	68,130 New	68,130 $1.77 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.